SG11201706861QA - Compositions and methods for the treatment of "plaques and tangles" in humans and animals - Google Patents
Compositions and methods for the treatment of "plaques and tangles" in humans and animalsInfo
- Publication number
- SG11201706861QA SG11201706861QA SG11201706861QA SG11201706861QA SG11201706861QA SG 11201706861Q A SG11201706861Q A SG 11201706861QA SG 11201706861Q A SG11201706861Q A SG 11201706861QA SG 11201706861Q A SG11201706861Q A SG 11201706861QA SG 11201706861Q A SG11201706861Q A SG 11201706861QA
- Authority
- SG
- Singapore
- Prior art keywords
- tangles
- plaques
- humans
- animals
- compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Cardiology (AREA)
- Physical Education & Sports Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Non-Alcoholic Beverages (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562126026P | 2015-02-27 | 2015-02-27 | |
US201562170822P | 2015-06-04 | 2015-06-04 | |
PCT/US2016/019572 WO2016138270A2 (en) | 2015-02-27 | 2016-02-25 | Compositions and methods for the treatment of "plaques and tangles" in humans and animals |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201706861QA true SG11201706861QA (en) | 2017-09-28 |
Family
ID=56789214
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201706861QA SG11201706861QA (en) | 2015-02-27 | 2016-02-25 | Compositions and methods for the treatment of "plaques and tangles" in humans and animals |
Country Status (10)
Country | Link |
---|---|
US (3) | US10307454B2 (zh) |
EP (1) | EP3261655A4 (zh) |
JP (1) | JP6796072B2 (zh) |
CN (1) | CN107530389B (zh) |
AU (1) | AU2016222650B2 (zh) |
CA (1) | CA3015127C (zh) |
HK (1) | HK1247845A1 (zh) |
MX (1) | MX2017010873A (zh) |
SG (1) | SG11201706861QA (zh) |
WO (1) | WO2016138270A2 (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6796072B2 (ja) | 2015-02-27 | 2020-12-02 | コグニティヴ クラリティ インコーポレイテッド | ヒトおよび動物における「プラークおよびもつれ」の処置のための組成物と方法 |
JP2022512372A (ja) | 2018-12-12 | 2022-02-03 | コグニティヴ クラリティ インコーポレイテッド | ヒトおよび動物における「プラークおよびタングル」の処置のための組成物および方法 |
US11883457B1 (en) | 2022-09-06 | 2024-01-30 | Optigenex Inc. | Method of enhancing cognition in individuals with at least normal cognition |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5683698A (en) | 1996-08-02 | 1997-11-04 | New England Deaconess Hospital | Formulation for alleviating symptoms associated with arthritis |
US6346280B1 (en) * | 1997-05-15 | 2002-02-12 | University Of Washington | Composition and methods for inhibiting the formation of brain amyloid deposits |
EP1019044B1 (en) * | 1997-05-15 | 2007-04-11 | University of Washington | Composition and methods for treating alzheimer's disease and other amyloidoses |
US6264994B1 (en) | 1997-05-15 | 2001-07-24 | University Of Washington | Compositions for treating alzheimer's disease and other amyloidoses |
CA2323090C (en) | 1998-03-13 | 2009-08-04 | University Of Washington | In vitro formation of congophilic maltese-cross amyloid plaques to identify anti-plaque therapeutics for the treatment of alzheimer's and prion diseases |
JP2003171298A (ja) * | 2001-12-11 | 2003-06-17 | Nonogawa Shoji Kk | 抗アレルギー剤 |
US8034387B2 (en) | 2002-04-30 | 2011-10-11 | Unigen, Inc. | Formulation of a mixture of free-B-ring flavonoids and flavans for use in the prevention and treatment of cognitive decline and age-related memory impairments |
US7244764B2 (en) | 2003-06-23 | 2007-07-17 | Neurochem (International) Limited | Methods and compositions for treating amyloid-related diseases |
EP1679060A1 (en) | 2003-10-09 | 2006-07-12 | Advangen, Inc. | Hair growth stimulant composition |
JP4321769B2 (ja) * | 2004-04-13 | 2009-08-26 | Towa Corporation 株式会社 | 抗ヒスタミン用組成物、アレルギ性鼻炎の予防および治療用組成物、花粉症の予防および治療用組成物およびじんま疹治療用組成物 |
JP4954552B2 (ja) * | 2006-01-07 | 2012-06-20 | 日本メナード化粧品株式会社 | 抗アレルギー剤 |
JP2007230977A (ja) * | 2006-03-03 | 2007-09-13 | Naris Cosmetics Co Ltd | 顆粒球・マクロファージコロニー刺激因子(gm−csf)産生抑制剤ii |
JP2007277163A (ja) | 2006-04-06 | 2007-10-25 | Uha Mikakuto Co Ltd | ジペプチジルペプチダーゼiv阻害剤 |
TW200812637A (en) * | 2006-09-15 | 2008-03-16 | jun-er Wang | Vegetable composition for cleaning oral cavity |
JP2010013423A (ja) | 2008-07-07 | 2010-01-21 | Lion Corp | ジペプチジルペプチダーゼ−iv阻害剤 |
JP5688606B2 (ja) | 2012-02-17 | 2015-03-25 | 株式会社シェフコ | 機能性原料を含有する水素含有飲料の製造方法 |
JP6796072B2 (ja) | 2015-02-27 | 2020-12-02 | コグニティヴ クラリティ インコーポレイテッド | ヒトおよび動物における「プラークおよびもつれ」の処置のための組成物と方法 |
-
2016
- 2016-02-25 JP JP2017545681A patent/JP6796072B2/ja active Active
- 2016-02-25 MX MX2017010873A patent/MX2017010873A/es unknown
- 2016-02-25 US US15/053,572 patent/US10307454B2/en active Active
- 2016-02-25 AU AU2016222650A patent/AU2016222650B2/en active Active
- 2016-02-25 CA CA3015127A patent/CA3015127C/en active Active
- 2016-02-25 EP EP16756363.4A patent/EP3261655A4/en active Pending
- 2016-02-25 SG SG11201706861QA patent/SG11201706861QA/en unknown
- 2016-02-25 WO PCT/US2016/019572 patent/WO2016138270A2/en active Application Filing
- 2016-02-25 CN CN201680019588.2A patent/CN107530389B/zh active Active
-
2017
- 2017-08-04 US US15/669,443 patent/US10350258B2/en active Active
-
2018
- 2018-06-07 HK HK18107417.0A patent/HK1247845A1/zh unknown
-
2019
- 2019-06-03 US US16/430,395 patent/US11376300B2/en active Active
Also Published As
Publication number | Publication date |
---|---|
WO2016138270A3 (en) | 2016-10-27 |
CN107530389A (zh) | 2018-01-02 |
CA3015127C (en) | 2023-10-10 |
JP2018513838A (ja) | 2018-05-31 |
EP3261655A4 (en) | 2018-10-10 |
US20190350996A1 (en) | 2019-11-21 |
US20170333512A1 (en) | 2017-11-23 |
WO2016138270A2 (en) | 2016-09-01 |
US10350258B2 (en) | 2019-07-16 |
HK1247845A1 (zh) | 2018-10-05 |
US20160250273A1 (en) | 2016-09-01 |
EP3261655A2 (en) | 2018-01-03 |
AU2016222650A1 (en) | 2017-09-07 |
CN107530389B (zh) | 2021-10-26 |
US11376300B2 (en) | 2022-07-05 |
AU2016222650B2 (en) | 2021-11-04 |
CA3015127A1 (en) | 2016-09-01 |
US20190240279A9 (en) | 2019-08-08 |
JP6796072B2 (ja) | 2020-12-02 |
MX2017010873A (es) | 2018-11-12 |
US10307454B2 (en) | 2019-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1258205A1 (zh) | 用於治療血紅蛋白病的組合物和方法 | |
IL268406A (en) | Preparations and methods for treating hemoglobin diseases | |
FI3889145T3 (fi) | 8-syaani-5-piperidinokinoliineja TLR7/8-antagonisteina ja niiden käyttö immunologisten häiriöiden hoitoon | |
IL298690B1 (en) | Preparations and methods for suppressing masp-3 for the treatment of various diseases and conditions | |
HK1253769A1 (zh) | 用於診斷和治療腎上腺腦白質營養不良的方法和組合物 | |
IL260352B (en) | Methods and preparations for the treatment of neurological disease | |
IL290150A (en) | Compounds and methods for treating chronic pain | |
IL275182A (en) | Preparations and methods for the treatment of metabolic conditions | |
HK1247845A1 (zh) | 用於在人和動物中處理"斑和纏結"的組合物和方法 | |
SG11201705524SA (en) | Compositions and methods for the treatment of inflammation and pain | |
LT3373922T (lt) | Kompozicijos ir būdai skirti naudoti homocistinurijos gydyme | |
HK1258073A1 (zh) | 治療細胞質糖原貯積失調的方法和組合物 | |
EP3496738C0 (en) | METHODS AND COMPOSITIONS FOR PREVENTING AND TREATING HEART DAMAGE | |
ZA201706985B (en) | Compositions for the treatment of fibrosis and fibrosis-related conditions | |
IL265911A (en) | Epilimod preparations and methods of using them in the treatment of Alzheimer's disease | |
ZA201801945B (en) | Compositions and methods for the treatment of parkinson's disease | |
IL259383A (en) | A compound for use in the prevention and treatment of neurodegenerative diseases | |
IL246608A0 (en) | Preparations and methods for treating heart disease | |
SG11202106222YA (en) | Compositions and methods for the treatment of "plaques and tangles" in humans and animals | |
ZA202004110B (en) | Compositions and methods for the treatment of metabolic conditions | |
IL243402A0 (en) | Methods for identifying preparations for use in the treatment of heart diseases and the use of preparations for the treatment of these diseases | |
GB201508518D0 (en) | Hair treatment compositions and methods |